Intangible Assets

9 Months Ended

12 Months Ended

Mar. 31, 2026

Jun. 30, 2025

4.	INTANGIBLE ASSETS

The following table summarizes the Company’s intangible assets:


	March 31, 2026			June 30, 2025
	$			$
Intellectual property		1,736,420			1,736,420
Patents		1,191,000			1,191,000

Intangible assets		2,927,420			2,927,420
Less: accumulated amortization		(1,428,947	)		(1,306,858	)

Intangible assets, net		1,498,473			1,620,562

Acquired intellectual property is recorded at cost and is amortized on a straight-line basis over 18 years. Acquired patents consist of patents related to the development of cannabinoid analogs. This intangible asset is being amortized over an estimated useful life of 18 years. As at March 31, 2026, the definite-lived intangible assets had a weighted average estimated remaining useful life of approximately 11 years. There was no impairment loss during the three and nine months ended March 31, 2026 and 2025.

Amortization expense on intangible assets for the three months ended March 31, 2026 and 2025 was approximately $41,000 and $41,000 respectively. Amortization expense on intangible assets for the nine months ended March 31, 2026 and 2025 was approximately $122,000 and $122,000 respectively. The Company expects amortization expense to be incurred over the next five years as follows:


Year ending June 30,	$
2026 (remaining)		40,687
2027		162,746
2028		162,746
2029		162,746
2030		162,746
Thereafter		806,802

Total		1,498,473

5.	INTANGIBLE ASSETS

The following table summarizes the Company’s intangible assets:


	June 30, 2025			June 30, 2024
	$			$
Intellectual property		1,736,420			1,736,420
Patents		1,191,000			1,191,000

Intangible assets		2,927,420			2,927,420
Less: accumulated amortization		(1,306,858	)		(1,144,222	)

Intangible assets, net		1,620,562			1,783,198

Acquired intellectual property is recorded at cost and is amortized on a straight-line basis over 18 years. Acquired patents consist of patents related to the development of cannabinoid analogs. This intangible asset is being amortized over an estimated useful life of 18 years. As at June 30, 2025, the definite-lived intangible assets had a weighted average estimated remaining useful life of approximately 11 years.

Amortization expense on intangible assets for the year ended June 30, 2025 and 2024 was $162,636 and $171,858 respectively. The Company expects amortization expense to be incurred over the next five years as follows:


Twelve months ending June 30,	$
2026		162,746
2027		162,746
2028		162,746
2029		162,746
2030		162,746
Thereafter		806,832

Total		1,620,562